New Immune-Focused Therapy Shrinks Aggressive Brain Tumors
THURSDAY, March 14, 2024 -- Delivering dual-targeted, immune-focused CAR T cancer therapy via a patient's spinal fluid quickly shrank deadly brain tumors, researchers report.CAR T therapy harnesses the power of the patient's immune system T-cells,...
What's Your Reaction?